IκBζ activity was markedly induced by CpG (a TLR ligand) in chronic lymphocytic leukemia (CLL) cells, and IκBζ controlled an oncogenic pathway relevant to mature B-cell neoplasia (134). Here, NFKBIZ is linked to B-cell chronic lymphocytic leukemia.